Goodwin’s Intellectual Property team regularly works on the most important deals in the life sciences and biotech sector. Our close relationship with clients ensures that the best intellectual property strategies are in place to foster company and product growth and minimize risk. We take pride in structuring, negotiating, and executing complex license, collaboration and joint
Latest Post
More Posts
Restructuring and Insolvency in the Life Sciences Sector: Q&A
European Life Sciences Deal Trends
Subscribe: Subscribe via RSS
Firm/Org